H2AX and pancreatic neoplasm: Intriguingly, an investigation was conducted on the γ-H2AX foci under various cellular conditions, including control, NLRP4 knockdown, NLRP4 overexpression in pancreatic cancer cells, and MitoQ treatment, after olaparib treatment.